Tech Company Inital Public Offerings
Morphic Holding IPO
Morphic Holding, based in Waltham, debuted as a public company on 6/26/2019.
Transaction Overview
Company Name
Announced On
6/26/2019
Transaction Type
IPO
Amount
$90,000,000
Proceeds Purpose
We currently intend to use the net proceeds we receive from this offering, as follows: approximately $30 million to $35 million to fund further development of our a4b7 program; approximately $15 million to $20 million to fund further development of our MInT Platform, to broaden our pipeline of product candidates; and any remaining amounts to fund working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
35 Gatehouse Dr. A2
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Morphic Holding (Nasdaq: MORF) is engaged in the discovery and development of small molecules to block transmembrane integrin receptors, which play a role in several diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Praveen Tipirneni
Chief Scientific Officer
Bruce Rogers
VP - Bus. Development
Alexey Lugovskoy
VP - Finance
Robert Farrell
Browse more venture capital transactions:
Prev: 6/26/2019: The Block venture capital transaction
Next: 6/26/2019: Software Motor Company venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs